Selected research
Market Structure
Global AI Clinical Trial Imaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global AI Clinical Trial Imaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of AI Clinical Trial Imaging include AICure, Brainomix, Clario, Lantern Pharma, Median, Neuroute, Owkin, PathAI and Quibim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global AI Clinical Trial Imaging market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Clinical Trial Imaging and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Clinical Trial Imaging revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Clinical Trial Imaging market size, projected growth trends, production technologies, key applications, and end-use industries.
AI Clinical Trial Imaging Segment by Company
AICure
Brainomix
Clario
Lantern Pharma
Median
Neuroute
Owkin
PathAI
Quibim
Saama
Spectral
VIDA
Voiant
AI Clinical Trial Imaging Segment by Type
Based on Machine Learning
Based on Deep Learning
Others
AI Clinical Trial Imaging Segment by Application
Telemedicine
Diagnostic Assistance
Clinical Decision Support
Others
AI Clinical Trial Imaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Trial Imaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Clinical Trial Imaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Clinical Trial Imaging industry.
Chapter 3: Detailed analysis of AI Clinical Trial Imaging companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Clinical Trial Imagingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Based on Machine Learning
- Based on Deep Learning
- Others
Applications
- Telemedicine
- Diagnostic Assistance
- Clinical Decision Support
- Others
Companies covered
- AICure
- Brainomix
- Clario
- Lantern Pharma
- Median
- Neuroute
- Owkin
- PathAI
- Quibim
- Saama
- Spectral
- VIDA
- Voiant
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global AI Clinical Trial Imaging Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Based on Machine Learning
- 1.2.3 Based on Deep Learning
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global AI Clinical Trial Imaging Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Telemedicine
- 1.3.3 Diagnostic Assistance
- 1.3.4 Clinical Decision Support
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global AI Clinical Trial Imaging Growth Trends by Region
- 1.5.1 Global AI Clinical Trial Imaging Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 AI Clinical Trial Imaging Market Size by Region (2021-2026)
- 1.5.3 AI Clinical Trial Imaging Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global AI Clinical Trial Imaging Market Dynamics
- 2.1 AI Clinical Trial Imaging Industry Trends
- 2.2 AI Clinical Trial Imaging Industry Drivers
- 2.3 AI Clinical Trial Imaging Industry Opportunities and Challenges
- 2.4 AI Clinical Trial Imaging Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global AI Clinical Trial Imaging Revenue by Company (2021-2026)
- 3.2 Global AI Clinical Trial Imaging Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global AI Clinical Trial Imaging Key Company Head office and Area Served
- 3.4 Global AI Clinical Trial Imaging Company, Product Type & Application
- 3.5 Global AI Clinical Trial Imaging Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global AI Clinical Trial Imaging Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 AI Clinical Trial Imaging Players Market Share by Revenue in 2025
- 3.6.3 2025 AI Clinical Trial Imaging Tier 1, Tier 2, and Tier 3
4 AI Clinical Trial Imaging Market by Type
- 4.1 Global AI Clinical Trial Imaging Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global AI Clinical Trial Imaging Market Size by Type (2021-2032)
- 4.3 Global AI Clinical Trial Imaging Market Size Share by Type (2021-2032)
5 AI Clinical Trial Imaging Market by Application
- 5.1 Global AI Clinical Trial Imaging Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global AI Clinical Trial Imaging Market Size by Application (2021-2032)
- 5.3 Global AI Clinical Trial Imaging Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 AICure
- 6.1.1 AICure Company Information
- 6.1.2 AICure Business Overview
- 6.1.3 AICure AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 AICure AI Clinical Trial Imaging Product Portfolio
- 6.1.5 AICure Recent Developments
- 6.2 Brainomix
- 6.2.1 Brainomix Company Information
- 6.2.2 Brainomix Business Overview
- 6.2.3 Brainomix AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Brainomix AI Clinical Trial Imaging Product Portfolio
- 6.2.5 Brainomix Recent Developments
- 6.3 Clario
- 6.3.1 Clario Company Information
- 6.3.2 Clario Business Overview
- 6.3.3 Clario AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Clario AI Clinical Trial Imaging Product Portfolio
- 6.3.5 Clario Recent Developments
- 6.4 Lantern Pharma
- 6.4.1 Lantern Pharma Company Information
- 6.4.2 Lantern Pharma Business Overview
- 6.4.3 Lantern Pharma AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Lantern Pharma AI Clinical Trial Imaging Product Portfolio
- 6.4.5 Lantern Pharma Recent Developments
- 6.5 Median
- 6.5.1 Median Company Information
- 6.5.2 Median Business Overview
- 6.5.3 Median AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Median AI Clinical Trial Imaging Product Portfolio
- 6.5.5 Median Recent Developments
- 6.6 Neuroute
- 6.6.1 Neuroute Company Information
- 6.6.2 Neuroute Business Overview
- 6.6.3 Neuroute AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Neuroute AI Clinical Trial Imaging Product Portfolio
- 6.6.5 Neuroute Recent Developments
- 6.7 Owkin
- 6.7.1 Owkin Company Information
- 6.7.2 Owkin Business Overview
- 6.7.3 Owkin AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Owkin AI Clinical Trial Imaging Product Portfolio
- 6.7.5 Owkin Recent Developments
- 6.8 PathAI
- 6.8.1 PathAI Company Information
- 6.8.2 PathAI Business Overview
- 6.8.3 PathAI AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 PathAI AI Clinical Trial Imaging Product Portfolio
- 6.8.5 PathAI Recent Developments
- 6.9 Quibim
- 6.9.1 Quibim Company Information
- 6.9.2 Quibim Business Overview
- 6.9.3 Quibim AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Quibim AI Clinical Trial Imaging Product Portfolio
- 6.9.5 Quibim Recent Developments
- 6.10 Saama
- 6.10.1 Saama Company Information
- 6.10.2 Saama Business Overview
- 6.10.3 Saama AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Saama AI Clinical Trial Imaging Product Portfolio
- 6.10.5 Saama Recent Developments
- 6.11 Spectral
- 6.11.1 Spectral Company Information
- 6.11.2 Spectral Business Overview
- 6.11.3 Spectral AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Spectral AI Clinical Trial Imaging Product Portfolio
- 6.11.5 Spectral Recent Developments
- 6.12 VIDA
- 6.12.1 VIDA Company Information
- 6.12.2 VIDA Business Overview
- 6.12.3 VIDA AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 VIDA AI Clinical Trial Imaging Product Portfolio
- 6.12.5 VIDA Recent Developments
- 6.13 Voiant
- 6.13.1 Voiant Company Information
- 6.13.2 Voiant Business Overview
- 6.13.3 Voiant AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Voiant AI Clinical Trial Imaging Product Portfolio
- 6.13.5 Voiant Recent Developments
7 North America
- 7.1 North America AI Clinical Trial Imaging Market Size (2021-2032)
- 7.2 North America AI Clinical Trial Imaging Market Size by Type
- 7.2.1 North America AI Clinical Trial Imaging Market Size by Type (2021-2026)
- 7.2.2 North America AI Clinical Trial Imaging Market Size by Type (2027-2032)
- 7.2.3 North America AI Clinical Trial Imaging Market Share by Type (2021-2032)
- 7.3 North America AI Clinical Trial Imaging Market Size by Application
- 7.3.1 North America AI Clinical Trial Imaging Market Size by Application (2021-2026)
- 7.3.2 North America AI Clinical Trial Imaging Market Size by Application (2027-2032)
- 7.3.3 North America AI Clinical Trial Imaging Market Share by Application (2021-2032)
- 7.4 North America AI Clinical Trial Imaging Market Size by Country
- 7.4.1 North America AI Clinical Trial Imaging Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America AI Clinical Trial Imaging Market Size by Country (2021-2026)
- 7.4.3 North America AI Clinical Trial Imaging Market Size by Country (2027-2032)
- 7.4.4 North America AI Clinical Trial Imaging Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe AI Clinical Trial Imaging Market Size (2021-2032)
- 8.2 Europe AI Clinical Trial Imaging Market Size by Type
- 8.2.1 Europe AI Clinical Trial Imaging Market Size by Type (2021-2026)
- 8.2.2 Europe AI Clinical Trial Imaging Market Size by Type (2027-2032)
- 8.2.3 Europe AI Clinical Trial Imaging Market Share by Type (2021-2032)
- 8.3 Europe AI Clinical Trial Imaging Market Size by Application
- 8.3.1 Europe AI Clinical Trial Imaging Market Size by Application (2021-2026)
- 8.3.2 Europe AI Clinical Trial Imaging Market Size by Application (2027-2032)
- 8.3.3 Europe AI Clinical Trial Imaging Market Share by Application (2021-2032)
- 8.4 Europe AI Clinical Trial Imaging Market Size by Country
- 8.4.1 Europe AI Clinical Trial Imaging Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe AI Clinical Trial Imaging Market Size by Country (2021-2026)
- 8.4.3 Europe AI Clinical Trial Imaging Market Size by Country (2027-2032)
- 8.4.4 Europe AI Clinical Trial Imaging Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China AI Clinical Trial Imaging Market Size (2021-2032)
- 9.2 China AI Clinical Trial Imaging Market Size by Type
- 9.2.1 China AI Clinical Trial Imaging Market Size by Type (2021-2026)
- 9.2.2 China AI Clinical Trial Imaging Market Size by Type (2027-2032)
- 9.2.3 China AI Clinical Trial Imaging Market Share by Type (2021-2032)
- 9.3 China AI Clinical Trial Imaging Market Size by Application
- 9.3.1 China AI Clinical Trial Imaging Market Size by Application (2021-2026)
- 9.3.2 China AI Clinical Trial Imaging Market Size by Application (2027-2032)
- 9.3.3 China AI Clinical Trial Imaging Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia AI Clinical Trial Imaging Market Size (2021-2032)
- 10.2 Asia AI Clinical Trial Imaging Market Size by Type
- 10.2.1 Asia AI Clinical Trial Imaging Market Size by Type (2021-2026)
- 10.2.2 Asia AI Clinical Trial Imaging Market Size by Type (2027-2032)
- 10.2.3 Asia AI Clinical Trial Imaging Market Share by Type (2021-2032)
- 10.3 Asia AI Clinical Trial Imaging Market Size by Application
- 10.3.1 Asia AI Clinical Trial Imaging Market Size by Application (2021-2026)
- 10.3.2 Asia AI Clinical Trial Imaging Market Size by Application (2027-2032)
- 10.3.3 Asia AI Clinical Trial Imaging Market Share by Application (2021-2032)
- 10.4 Asia AI Clinical Trial Imaging Market Size by Country
- 10.4.1 Asia AI Clinical Trial Imaging Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia AI Clinical Trial Imaging Market Size by Country (2021-2026)
- 10.4.3 Asia AI Clinical Trial Imaging Market Size by Country (2027-2032)
- 10.4.4 Asia AI Clinical Trial Imaging Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa AI Clinical Trial Imaging Market Size (2021-2032)
- 11.2 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Type
- 11.2.1 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa AI Clinical Trial Imaging Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Application
- 11.3.1 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa AI Clinical Trial Imaging Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Country
- 11.4.1 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa AI Clinical Trial Imaging Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa AI Clinical Trial Imaging Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst